response

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

April 10, 2026 17:02 ET  | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

4 days ago

J.S. Held Strengthens Cross-Disciplinary Response to Artificial Intelligence (AI) Disputes

Delivering technical clarity, financial calculus, and courtroom credibility in AI-related litigation.NEW YORK, April 9, 2026 /PRNewswire/ -- J.S. Held announced…

4 days ago

Pivotal Launches eVTOL Emergency Response Operations with Hyde County, North Carolina and Code Blue Resources

PALO ALTO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Pivotal, the market leader in light electric Vertical Takeoff and Landing…

1 month ago

Expedience Software Recognized as a Representative Vendor in the 2025 Gartner Market Guide for RFP Response Management Applications

MANCHESTER, N.H., March 04, 2026 (GLOBE NEWSWIRE) -- Expedience Software, a leading provider of proposal automation technology, today announced its…

1 month ago

Coway Issues Official Response to Align Partners’ Second Proposal, Reaffirms Commitment to Shareholders and Sustainable Growth

Coway proves record-breaking growth through core strategies led by Chairman Junhyuk BangThe company is also strengthening transparency in 2026 with…

2 months ago

Phaos Technology Holdings (Cayman) Limited Provides Response to Unusual Market Action

SINGAPORE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“the Company”), an advanced microscopy…

2 months ago

Atos positioned as a Leader in the IDC MarketScape: Middle East Managed Detection and Response (MDR) 2025 Vendor Assessment

Press Release Atos positioned as a Leader in the IDC MarketScape™: Middle East Managed Detection and Response (MDR) 2025 Vendor…

2 months ago

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja (leniolisib) in children aged 4 to 11 years with APDS

Leiden, the Netherlands, February 1, 2026: Pharming Group (Euronext: PHARM; Nasdaq: PHAR) today announced that the U.S. Food and Drug…

2 months ago

ACTFORE Secures Patent for Template Identification and Matching Technology, Transforming Large-Scale Document Analysis in Breach Response

RESTON. Va., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ACTFORE, a leading provider of AI-powered breach response and data mining solutions,…

2 months ago

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…

3 months ago